Lunch & Industry Symposium presented by Interventional Oncology at Johnson & Johnson (INTO) - Novel Intratumoral Cancer Treatments and the Expanding Role of the Interventional Radiologist

Lunch and Industry Symposium presented by Interventional Oncology at Johnson & Johnson (INTO) - Novel Intratumoral Cancer Treatments and the Expanding Role of the Interventional Radiologist

Moderator: Kamyar Farahi, PhD, Head, Scientific Engagement & Education, Global Scientific Affairs, INTO at J&J

Harnessing Pharma and Medical Technology Expertise to Eliminate Cancer through Intratumoral Treatments, Hannah McEwen, PhD, Vice President, Engineering Sciences, INTO at J&J
Understanding Unmet Needs in Cancer Treatment and Expanding IR’s Role in the Evolving Landscape, Robert Short MD, PhD, Vascular Interventional Radiologist, Associate Professor, Radiology, Surgery, Biomedical Engineering, Wright State University, Boonshoft School of Medicine